Catalog No.:AA000N0A

125068-54-4 | 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]-

Name: Name:3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]-
Brand: AABLOCKS
SKU: AA000N0A
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

1mg

95%

1 week

$149.00 $104.00

- +

2mg

95%

1 week

$192.00 $135.00

- +

5mg

95%

1 week

$283.00 $198.00

- +

10mg

95%

1 week

$443.00 $310.00

- +

25mg

95%

1 week

$711.00 $498.00

- +

50mg

95%

1 week

$992.00 $695.00

- +

100mg

95%

1 week

$1,349.00 $944.00

- +

500mg

95%

1 week

$2,663.00 $1,864.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA000N0A

Chemical Name:

3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]-

CAS Number:

125068-54-4

Molecular Formula:

C17H19N3O2

Molecular Weight:

297.3517

MDL Number:

MFCD00887290

SMILES:

O=C1NN=C(C(C1)C)c1ccc(cc1)NC1=C(C)C(=O)CC1

Properties

Computed Properties

Complexity:

542

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

Undefined Atom Stereocenter Count:

XLogP3:

1.7

Literature

Title: [The effect of phosphodiesterase type 3 inhibitor on chorio-retinal blood flow in rabbits eyes].

Journal: Nippon Ganka Gakkai zasshi 20021001

Title: Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.

Journal: Journal of cardiovascular pharmacology 19930601

Title: Mochizuki N, et al. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties. J Cardiovasc Pharmacol. 1993 Jun;21(6):983-95.

Title: Uchida H, et al. [The effect of phosphodiesterase type 3 inhibitor on chorio-retinal blood flow in rabbits eyes Nippon Ganka Gakkai Zasshi. 2002 Oct;106(10):615-20.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS